Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
IPO Year:
Exchange: NYSE
Website: integer.net
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/16/2024 | $135.00 | Outperform | Oppenheimer |
5/15/2024 | $137.00 | Buy | Truist |
4/15/2024 | $105.00 → $135.00 | Neutral → Buy | BofA Securities |
3/14/2024 | $137.00 | Buy | CL King |
2/6/2024 | $125.00 | Overweight | KeyBanc Capital Markets |
5/26/2023 | $87.00 | Equal Weight | Wells Fargo |
5/11/2023 | $88.00 | Neutral | Citigroup |
3/30/2023 | $86.00 | Neutral | BofA Securities |
2/24/2023 | $85.00 | Overweight | Piper Sandler |
3/1/2022 | $111.00 → $109.00 | Overweight | Keybanc |
SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company's rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company's majority owner upon closing of the rights offering and conversion of Patient Square's senior secured convertible notes per its investment in June 2022. As previously announced, following the completion of the rights offering, Patient Square has the right to nominate a number of directors t
PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as Chair of the Integer Board of Directors at the conclusion of the Company's 2022 annual meeting of stockholders, which is scheduled to be held on May 18, 2022. Commensurate with this carefully planned transition, the Board of Directors plans to appoint current long-standing Integer Board member Pamela G. Bailey to serve as the next Chair of the Board. "On behalf of the Integer Board of Directors, I wish to thank Bill for his immense contribution and insightful leadership over the past 22 ye
10-Q - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
SD - Integer Holdings Corp (0001114483) (Filer)
10-Q - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
ARS - Integer Holdings Corp (0001114483) (Filer)
DEFA14A - Integer Holdings Corp (0001114483) (Filer)
2024 Outlook(a) (dollars in millions, except per share amounts) GAAP Non-GAAP(b) As Reported Change from Prior Year Adjusted Change from Prior Year Sales $1,735 to $1,770 9% to 11% N/A N/A Operating income $202 to $220 21% to 31% $275 to $293 14% to 21% EBITDA N/A N/A $357 to $377 15% to 22% Net income $116 to $130 28% to 44% $174 to $189 11% to 20% Diluted earnings per share $3.26 to $3.67 21% to 37% $5.07 to $5.49 9% to 18% Cash flow from operating activities $185 to $205 3% to 14% N/A N/A
During the last three months, 5 analysts shared their evaluations of Integer Holdings (NYSE:ITGR), revealing diverse outlooks from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 3 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $131.2, a high estimate of $137.00
Oppenheimer analyst Suraj Kalia initiates coverage on Integer Holdings (NYSE:ITGR) with a Outperform rating and announces Price Target of $135.
Citigroup analyst Joanne Wuensch maintains Integer Holdings (NYSE:ITGR) with a Neutral and raises the price target from $118 to $124.
Truist Securities initiated coverage on Integer Holdings Corporation (NYSE:ITGR), noting the company as one of the largest med device outsource manufacturers and a unique SMID MedTech asset. The analyst notes Integer’s profitability and leveraged EPS growth prospects (1.5-2x that of revenue), which can sustain a high-teens 2023-2026 EPS CAGR. Integer has increasing exposure (through the OEM supply chain) to growth segments & emerging product cycles across the MedTech sector, Truist writes. Also, a durable inorganic (tuck-in) strategy can add at least 1-2%+ on top of a high-single-digit organic top-line, the analyst adds. Related: Medical Device Manufacture Integer To Gain From Ex
Analysts' ratings for Integer Holdings (NYSE:ITGR) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 3 0 0 0 0 2M Ago 1 1 0 0 0 3M Ago 0 1 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $132.0, with a high estimate of $139.00 and a low estimate of $123.00. This current average has increased by 15.28% fr
Truist Securities analyst Richard Newitter initiates coverage on Integer Holdings (NYSE:ITGR) with a Buy rating and announces Price Target of $137.
Benchmark analyst Robert Wasserman reiterates Integer Holdings (NYSE:ITGR) with a Buy and maintains $130 price target.
Integer Holdings (NYSE:ITGR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $130.33, a high estimate of $139.00, and a low estimate of $123.00. Surpassing the previous average price target o
PLANO, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation at the Wells Fargo 2024 Healthcare Conference, to be held Sept. 4 – 6, 2024, in Boston. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Wednesday, Sept. 4, at 2:15 pm EDT. A live webcast of the presentation will be accessible under "News & Events" on the Investor Relations section of the Integer website at investor.integer.net. Learn more about Integer at www.integer.net. About Integer®Integer Holdings Corporation (NYSE:ITGR) is one of the large
~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 28, 2024. Second Quarter 2024 Highlights (compared to Second Quarter 2023, except as noted) Sales increased 9% to $436 million, with organic growth of 5%.GAAP net income increased $7 million to $31 million, an increase of 30%. Non-GAAP adjusted net income increased $7 million to $45 million, an increase of 17%.GAAP operating income increased $14 million to $55 million, an increase of 33%. Non-GAAP adjusted operating income increased $12
PLANO, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) ("Integer" or the "Company"), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the "Notes") that the Notes are convertible, at the option of the holders (the "Conversion Option") beginning on July 1, 2024, and ending at the close of business on September 30, 2024. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversi
PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q2 2024 Integer H
PLANO, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the 2024 Truist Securities MedTech Conference, to be held June 17 – 18, 2024, in Boston. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present as part of a fireside chat on Tuesday, June 18, at 1:55 p.m. ET. A live webcast of the presentation will be accessible under "News & Events" on the Investor Relations section of the Integer website at investor.integer.net. Learn more about Integer at www.integer.net. About Integer®Integer Holdings Corpor
PLANO, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization (CDMO), will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society (HRS) educational event and exhibition in Boston from May 16 – 19, 2024. HRS attendees are invited to visit Integer at booth #753 to learn more about the company's comprehensive end-to-end solutions, designed to help customers accelerate time to market, strengthen innovation, simplify supply chain and confidently scale production across a globally competitive network of locations. Some examples include marke
PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Tuesday, May 14, at 10:40 a.m. PDT. A live webcast of the presentation will be accessible under "News & Events" on the Investor Relations section of the Integer website at investor.integer.net. Learn more about Integer at www.integer.net. About Integer®Integer Holdings Corporation (NYSE:ITGR) is
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%.GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income increased $10 million to $39 million, an increase of 33%.GAAP operating income increased $5 million to $39 million, an increase of 15%. Non-GAAP adjusted operating income increased $13 mil
PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (888) 330-3567International dial-in number: (646) 960-0842Conference ID: 9252310Webcast Registration: ITGR Q1 20
PLANO, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:15 a.m. ET on Tuesday, March 19, 2024. A live webcast of the presentation will be accessible under "News & Events" on the Investor Relations section of the Integer website at investor.integer.net. About Integer®Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac rhythm management, neuromodulation, vascular, portable medical and orthopedi
~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 28, 2024. Second Quarter 2024 Highlights (compared to Second Quarter 2023, except as noted) Sales increased 9% to $436 million, with organic growth of 5%.GAAP net income increased $7 million to $31 million, an increase of 30%. Non-GAAP adjusted net income increased $7 million to $45 million, an increase of 17%.GAAP operating income increased $14 million to $55 million, an increase of 33%. Non-GAAP adjusted operating income increased $12
PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q2 2024 Integer H
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%.GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income increased $10 million to $39 million, an increase of 33%.GAAP operating income increased $5 million to $39 million, an increase of 15%. Non-GAAP adjusted operating income increased $13 mil
PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (888) 330-3567International dial-in number: (646) 960-0842Conference ID: 9252310Webcast Registration: ITGR Q1 20
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 9% to 11% sales growth in 2024 with expanding margins ~ PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022, except as noted) Sales increased 11% to $413 million.GAAP income from continuing operations increased $9 million to $26 million, an increase of 54%. Adjusted net income increased $1
~ Preliminary unaudited full year 2023 sales increase 16% versus 2022 ~~ Acquisition adds highly differentiated micro machining capability in high growth end markets ~~ Schedules conference call for fourth quarter and full year 2023 results ~ PLANO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022. Preliminary unaudited full year 2023 sales are expected to be in the range of $1.595 billion to $1.597 billion, an increase of
~ Delivered strong performance with 3Q23 financial results ~~ Increasing full year 2023 outlook ~ PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023. Third Quarter 2023 Highlights (compared to Third Quarter 2022, except as noted) Sales increased 18% to $405 million, with organic growth of 18%.GAAP net income increased $11 million to $27 million, an increase of 70%. Non-GAAP adjusted net income increased $11 million to $43 million, an increase of 35%.GAAP operating income increased $19 million to $48 million, an in
PLANO, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 26, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, October 26, 2023Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (888) 330-3567International dial-in number: (646) 960-0842Conference ID: 9252310Webcast Registration: ITGR Q3 20
~ Continued strong performance with 2Q23 financial results ~~ Increasing full year 2023 outlook ~ PLANO, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended June 30, 2023. Second Quarter 2023 Highlights (compared to Second Quarter 2022, except as noted) Sales increased 14% to $400 million, with organic growth of 14%.GAAP net income increased $3 million to $24 million, an increase of 15%. Non-GAAP adjusted net income increased $4 million to $38 million, an increase of 11%.GAAP operating income increased $9 million to $42 million, an increase of 27%. Non-GAAP
PLANO, Texas, June 29, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 27, 2023Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (888) 330-3567International dial-in number: (646) 960-0842Conference ID: 9252310Webcast Registration: ITGR Q2 2023
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
Oppenheimer initiated coverage of Integer Holdings with a rating of Outperform and set a new price target of $135.00
Truist initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00
BofA Securities upgraded Integer Holdings from Neutral to Buy and set a new price target of $135.00 from $105.00 previously
CL King initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00
KeyBanc Capital Markets resumed coverage of Integer Holdings with a rating of Overweight and set a new price target of $125.00
Wells Fargo initiated coverage of Integer Holdings with a rating of Equal Weight and set a new price target of $87.00
Citigroup initiated coverage of Integer Holdings with a rating of Neutral and set a new price target of $88.00
BofA Securities initiated coverage of Integer Holdings with a rating of Neutral and set a new price target of $86.00
Piper Sandler initiated coverage of Integer Holdings with a rating of Overweight and set a new price target of $85.00
Keybanc reiterated coverage of Integer Holdings with a rating of Overweight and set a new price target of $109.00 from $111.00 previously